Phathom Pharmaceuticals Inc (PHAT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -143,883 | -108,057 | -71,395 | -34,843 | -129,068 |
| Depreciation Amortization | 4,116 | 3,474 | 954 | 489 | 1,596 |
| Other Working Capital | -27,315 | -15,938 | -16,283 | -19,586 | 51,717 |
| Other Operating Activity | 18,625 | 13,326 | 8,595 | 4,175 | 6,067 |
| Operating Cash Flow | $-148,457 | $-107,195 | $-78,129 | $-49,765 | $-69,688 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -328 | -228 | -214 | -169 | -1,040 |
| Investing Cash Flow | $-328 | $-228 | $-214 | $-169 | $-1,040 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 96,889 | 96,889 | N/A | N/A | 25,000 |
| Debt Repayment | -54,125 | -54,125 | N/A | N/A | N/A |
| Common Stock Issued | 1,944 | 1,781 | 516 | 412 | 89,459 |
| Financing Cash Flow | $44,708 | $44,545 | $516 | $412 | $114,459 |
| Beginning Cash Position | 287,496 | 287,496 | 287,496 | 287,496 | 243,765 |
| End Cash Position | 183,419 | 224,618 | 209,669 | 237,974 | 287,496 |
| Net Cash Flow | $-104,077 | $-62,878 | $-77,827 | $-49,522 | $43,731 |
| Free Cash Flow | |||||
| Operating Cash Flow | -148,457 | -107,195 | -78,129 | -49,765 | -69,688 |
| Capital Expenditure | -328 | -228 | -214 | -169 | -1,040 |
| Free Cash Flow | -148,785 | -107,423 | -78,343 | -49,934 | -70,728 |